diet market

Medifast To Launch National Marketing Campaign

May 20, 2024 Medifast today announced the launch of the first phase of its multimillion-dollar national marketing campaign. The campaign will highlight OPTAVIA’s new offering in collaboration with LifeMD®, the GLP-1 Lifestyle Program. View the full release here: https://www.businesswire.com/news/home/20240520770526/en/ This will be an investment of up to $30 million in company-led marketing efforts. Medifast is committed […]

Medifast To Launch National Marketing Campaign Read More »

More Obesity Drugs In The Pipeline

Uncategorized / John LaRosa

January 20, 2024 Novo Nordisk and Eli Lilly aren’t the only drug companies active in the prescription diet drugs space. Viking Therapeutics has a dual GLP-1/GIP agonist in Phase 2 clinical trials for treating obesity and liver fat reduction for injectable and oral administration. Rhythm Pharmaceuticals has an FDA-approved treatment for the treatment of MC4R-pathway-related

More Obesity Drugs In The Pipeline Read More »

Weight Watchers Reports 3rd Quarter Results

News / John LaRosa

November 2, 2023 WW reported results for its 3rd quarter. Management reported that: “We have successfully returned WeightWatchers to subscriber growth, with Q3 end of period subscribers up 6% year-over-year to 4.0 million. This is a significant achievement and a direct result of our work in reinvigorating our core product,” said Sima Sistani, the company’s

Weight Watchers Reports 3rd Quarter Results Read More »

WW Reports Q1 2021 Results

News, Uncategorized / John LaRosa

May 6, 2021 Weight Watchers reported its 1st quarter performance yesterday. “…WW had a strong start to the year, ending Q1 with 5.0 million subscribers, record Digital subscribers, and member retention remaining at an all-time high of over 10 months,” said Mindy Grossman, the Company’s President and CEO. “…Our continued digital transformation to a personalized,

WW Reports Q1 2021 Results Read More »

WW Reports Q1 2020 Results

News / John LaRosa

April 28, 2020 WW (Weight Watchers reported today that: Q1 2020 End of Period Subscribers up 9% year-over-year to 5.0 million, an all-time Q1-end high. Q1 2020 Revenues of $400 million, up 10%, or 11% on a constant currency basis, year-over-year. Launches Virtual Workshops globally, as a response to Studio closures, keeping the WW community

WW Reports Q1 2020 Results Read More »

Medifast Beats on Earnings & Revenues, Q4, full-year report

News / John LaRosa

Feb. 27, 2020 Medifast (MED) posted revenues of $170.63 million for the 4th quarter ended December 2019, surpassing the Consensus Estimate by 5.33%. This compares to year-ago revenues of $145.8 million. The company has topped consensus revenue estimates three times over the last four quarters. Fourth Quarter 2019 Highlights Compared to Prior-Year Period Revenue up

Medifast Beats on Earnings & Revenues, Q4, full-year report Read More »

Walgreens Partners With Jenny Craig

News / John LaRosa

Oct. 28, 2019 Jenny Craig and Walgreens will open 100 Jenny Craig at Walgreens locations nationwide in January 2020. This collaboration marks the first time Jenny Craig will offer its services at a national drugstore chain in the U.S. and the first time customers will be able to receive personalized health and weight loss management

Walgreens Partners With Jenny Craig Read More »

Marketdata Publishes New Weight Loss Market Study – Market Tops $72 Billion

News / John LaRosa

Marketdata LLC, Tampa, FL (www.marketdataenterprises.com) has just released its new 15th edition of “The U.S. Weight Loss & Diet Control Market”, a 457-page detailed analysis / market research report. The report costs $1,895 at the Marketdata website (report #FS67). Also sold by single chapters–call for prices. $99 Executive Overview, 44 pp. This is the 30th

Marketdata Publishes New Weight Loss Market Study – Market Tops $72 Billion Read More »

(813) 971-8080